Stay updated on Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows Revision: v3.4.2 and a funding/status notice was removed. These are administrative updates that do not affect study data, eligibility criteria, outcomes, or how users interact with the page.
    Difference
    0.4%
    Check dated 2026-02-11T11:17:19.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Notice about government funding and NIH Clinical Center status added. Site revision updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:37:15.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated page metadata to reflect the latest revision (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). Removed the older metadata entries (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T06:17:55.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision notes updated: v3.3.4 added and v3.3.3 removed.
    Difference
    0.1%
    Check dated 2026-01-14T03:03:09.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Florida location to the study Locations section and removed the separate Florida Locations entry; page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:25:20.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The Publications section now clarifies that publications are provided voluntarily and relate to the study results. A revision note 'Revision: v3.3.2' was added.
    Difference
    0.1%
    Check dated 2025-11-24T21:59:08.000Z thumbnail image

Stay in the know with updates to Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Axitinib & Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.